Nanoformulations of essential oils for the treatment of fungal diseases, with a focus on dermatophytes
Archives of Microbiology · 2026
DOI: 10.1007/s00203-026-04746-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Ghulam Muhayyudin Chattha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. gmchattha234@gmail.com. Hauptthemen laut MEDLINE: Oils, Volatile, Antifungal Agents, Arthrodermataceae, Dermatomycoses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 308 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Do Rio Grande Do Sul.
Abstract (Originalsprache)
Fungal infections, particularly those caused by dermatophytes, affect over 25% of the world's population and pose a significant public health risk to both humans and animals. Conventional antifungal treatments face substantial challenges like drug resistance, adverse effects, and require long-term systemic medications. Essential oils (EOs) have attracted attention for their antimicrobial properties; however, their therapeutic applications have been hampered by their low solubility and rapid degradation. Nanotechnology addresses these limitations by encapsulating EOs to enhance their durability, bioavailability, and antifungal properties. This review covers the potential EO-based nanoformulations for treating fungal infections, with a focus on dermatophytes. It also highlights how nanoencapsulation may help reduce drug resistance, toxicity, and adverse effects. However, there are some limitations. The effectiveness of treating fungal infection can vary depending on the EO's composition, fungal species, and how the nanoformulation is formulated. Future research should emphasize standardizing formulation protocol and evaluating in vivo efficacy and safety through well-designed clinical trials. While EOs represent a promising approach, they are not a substitute for evidence-based antifungal treatment and must not be used without medical guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. gmchattha234@gmail.com.
- Post-Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. gmchattha234@gmail.com.
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Post-Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. lucelia.santi@ufrgs.br.
- Post-Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. lucelia.santi@ufrgs.br.
Förderung
- Universidade Federal Do Rio Grande Do Sul
Zitieren
APA
Chattha, G. M., de Andrades Cappellari, Y. L. R., Beys-da-Silva, W. O., Frank, L. A., & Santi, L. (2026). Nanoformulations of essential oils for the treatment of fungal diseases, with a focus on dermatophytes. Archives of Microbiology. https://doi.org/10.1007/s00203-026-04746-4
Vancouver
Chattha GM, de Andrades Cappellari YLR, Beys-da-Silva WO, Frank LA, Santi L. Nanoformulations of essential oils for the treatment of fungal diseases, with a focus on dermatophytes. Archives of Microbiology. 2026. doi:10.1007/s00203-026-04746-4
BibTeX
@article{Chattha2026,
author = {Chattha, Ghulam Muhayyudin and de Andrades Cappellari, Yasmin Louise Ramos and Beys-da-Silva, Walter Orlando and Frank, Luiza Abrahão and Santi, Lucélia},
title = {Nanoformulations of essential oils for the treatment of fungal diseases, with a focus on dermatophytes},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-026-04746-4}
}
EUVIMED